Do you have questions?

A Contract Development and Manufacturing Organisation (CDMO) is a specialist partner that supports pharmaceutical and biotech companies throughout the development and manufacturing of drug products. By combining technical expertise, regulatory understanding and production capabilities, a CDMO helps turn scientific concepts into reliable, high-quality products throughout the whole lifecycle.
At LTS, we have a somewhat unique model where we support partners who are adopting an LTS platform as well as those who have developed their own technology and need a high-quality manufacturing partner that can deliver global volumes.

Supporting innovation from concept to market
Bringing a pharmaceutical product to market requires far more than a promising molecule. It demands careful development, robust process design and a manufacturing strategy that can support the entire development process from feasibility, first prototypes, clinical trials through to commercial launch and lifecycle management. A CDMO provides the capabilities needed to move efficiently through these stages while helping partners maintain focus on their core scientific objectives.

What a CDMO offers
A CDMO typically offers integrated services across the full product lifecycle. These may include formulation development, analytical testing, process optimisation, scale-up, clinical manufacturing, validation, and commercial production.
By bringing these functions together within one consistent and valued partnership, pharma companies create a more seamless path from early development to market supply. This integrated approach can help reduce complexity, improve coordination, and support greater continuity across each phase of development.

Why choose a LTS as your CDMO?
Working with a CDMO offers important strategic advantages. It reduces the need for major investment in facilities, equipment, and specialised skils, while providing access to proven technical knowledge and manufacturing experience. In the case of LTS, this expertise and know how extends across a wide range of delivery technologies including Transdermal Therapeutic Systems, Oral Thin Films, Microneedle Array Patches, Topical Patch Systems, On Body Delivery Systems and Nasal Drug Delivery. To find out more about our technology platforms click here
For our partners, this model offers flexibility and speed, allowing its teams to adapt to changing development needs, respond to regulatory expectations and scale production with confidence.

Expertise matters
In pharmaceutical development, expertise is essential. Each product presents unique scientific, technical, and regulatory challenges, and success depends on the ability to manage them with precision. A strong CDMO partner does more than provide capacity. It contributes insight, continuity and execution across the entire journey, helping ensure that development and manufacturing are aligned with long-term product goals.

A partner for progress
As the pharmaceutical industry continues to evolve, the role of the CDMO becomes increasingly important. Pharma companies are seeking trusted partners who can combine innovation with operational excellence and support the delivery of high-quality products to patients around the world.
For more information on our CDMO capabilities, click here